These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3103412)

  • 1. Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.
    Sharpe N; Coxon R; Webster M; Luke R
    Am J Cardiol; 1987 Apr; 59(8):895-9. PubMed ID: 3103412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
    Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
    Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure.
    Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J
    Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
    Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin.
    Rajfer SI; Demma FJ; Goldberg LI
    Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
    Bolognese L; Sarasso G; Rognoni G; Makmur J; Fornaro G; Perucca A; Rossi P
    Clin Cardiol; 1988 Feb; 11(2):79-85. PubMed ID: 3126012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U; Roth A; Henriquez B; Weber L; Tonnemacher D; Rahimtoola SH
    Am J Cardiol; 1985 Sep; 56(8):555-9. PubMed ID: 3929585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
    Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
    Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effect and duration of action of Deponit 10 in patients with congestive heart insufficiency].
    Vogt A; Kreuzer H
    Z Kardiol; 1986; 75 Suppl 3():86-9. PubMed ID: 3099488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of nitroglycerin ointment in congestive heart failure.
    Taylor WR; Forrester JS; Magnusson P; Takano T; Chatterjee K; Swan HJ
    Am J Cardiol; 1976 Oct; 38(4):469-73. PubMed ID: 823808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
    Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
    Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.
    Olivari MT; Carlyle PF; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Nov; 2(5):872-8. PubMed ID: 6415142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrate tolerance in heart failure: differential venous, pulmonary and systemic arterial effects.
    Makhoul N; Dakak N; Flugelman MY; Merdler A; Shefer A; Schneeweiss A; Halon DA; Lewis BS
    Am J Cardiol; 1990 Jun; 65(21):28J-31J. PubMed ID: 2112336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A transdermal intermittent-release nitroglycerin system. Hemodynamic studies after acute and subchronic use].
    Weber K; Bergbauer M; Ricken D
    Dtsch Med Wochenschr; 1989 Oct; 114(41):1551-6. PubMed ID: 2509186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
    Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
    Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous versus intermittent nitroglycerin administration in experimental heart failure: vascular relaxation and radioligand binding to adrenoceptors and ion channels.
    Bauer JA; Fung HL; Zheng W; Kwon YW; Gopalakrishnan M; Triggle DJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):600-8. PubMed ID: 7505363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transdermal therapeutic system-nitroglycerin in patients with heart failure. Influence on hemodynamic changes.
    Ino-Oka E; Takishima T; Onodera K; Kato M; Hayashi M; Yasui S
    Jpn J Med; 1989; 28(6):697-708. PubMed ID: 2517442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.